Plus, news about Oruka Therapeutics, Centessa, Takeda, Innate Pharma and Liquidia: GSK’s mRNA flu vaccine succeeds against both strains in Phase 2: The pharma company ...

Senate Finance Committee Chair Ron Wyden (D-OR) is urging HHS to take a stronger stance on healthcare companies' cybersecurity practices as the healthcare system is still piecing together what ...

Bristol Myers Squibb said its KRAS cancer drug Krazati met the primary endpoint in a Phase 3 confirmatory trial in patients with non-small cell lung cancer, according to new data ...

Merck and Kelun-Biotech revealed Phase 3 breast cancer data for the lead antibody-drug conjugate in their potentially $12 billion partnership. In a Phase 3 trial for locally recurrent or ...

April 29, 2024 05:53 PM EDT Updated 06:48 PM ...

To help meet the heightened demand for its injectable products, Eli Lilly is acquiring a facility from Nexus Pharmaceuticals, with production anticipated to start at the end of next year ...

March 11, 2024 04:54 AM EDT Updated March 12, 06:55 PM ...

Reps. Kel­ly Arm­strong (R-ND) and Ben Cline (R-VA) sent a let­ter last week to At­tor­ney Gen­er­al Mer­rick Gar­land, ask­ing why the De­part­ment of Jus­tice is … ...

ARCH Venture Partners plans to raise $3 billion for its 13th fund, per a new SEC filing from this week. The Chicago-based venture capital firm has ...

Small molecule biotech Totus Medicines has closed a $66 million Series B to carry its PI3Kα inhibitor through Phase Ia and has named Nassim Usman as its new president and ...

The Biden administration’s new biomedical research agency is launching a $24.8 million project to develop mRNA platforms with the goal of using the technology to fight cancer and other life ...

Bristol Myers Squibb plans to let go of 108 employees in New Jersey, citing an “evolving” business model. The layoffs, set to go into effect Nov. 2, will affect employees ...